Non-Viral, Plasmid-Free CAR T-Manufacturing Platform Begins Preclinicals
Goal Is the Development of Faster, More Affordable Therapies
Building the Ideal Bioprocessing Strategy
Searching for Innovative, Cost-Effective Product Options
Diet, the Gut Microbiome, and Colorectal Cancer: Are They Linked?
Updates on Microbial Associations and Therapeutic Implications
Improved Assays and Predictive Tools for Drug Lead Optimization
Advanced Strategies to Study Plasma Protein Binding, Improve PK/PD, and Develop Better Enzyme Inhibitors